跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,231 条关于
“RAS/MAPK”
全部
9,231
临床试验
5,044
药物
565
机构
232
资讯
3,390
3年前
Lorlatinib Shows Promise in ALK-Driven Refractory Neuroblastoma with Emerging Resistance Mechanisms Identified
去年
Trametinib Shows Promise in Treating Severe Hypertrophic Cardiomyopathy in Children
9个月前
Verastem Oncology Restructures Leadership to Advance KRAS-Targeted Cancer Pipeline
去年
Verastem Oncology to Present New LGSOC Treatment Data at SGO 2025 Annual Meeting
2年前
Verastem's Avutometinib and Defactinib Combination Therapy Shows Promise in LGSOC and Other Cancers
去年
Immuneering Partners with Lilly for Phase 2 NSCLC Combination Trial Testing Dual MAPK Pathway Blockade
8个月前
Verastem Discontinues KRAS G12C Trial to Focus on Promising G12D Inhibitor with 69% Response Rate
去年
Pasithea Therapeutics Raises $6.3 Million to Advance MEK Inhibitor for Neurofibromatosis Type 1
去年
Verastem Oncology Completes FDA Submission for Avutometinib Plus Defactinib in Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
去年
Verastem Oncology Refinances Debt and Advances Avutometinib/Defactinib Combination
第 1 页,共 339 页
上一页
下一页